Drug: GLUCOVANCE Injury: Gastrointestinal carcinoma Quarter: 2016Q3
Total Records: 4 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124382974 | GLUCOVANCE | Gastrointestinal carcinoma | GLAXOSMITHKLINE | 66.38 YR | F | 68 KG | 20160722 | US |
124510323 | GLUCOVANCE | Gastrointestinal carcinoma | NOVO NORDISK | 66.00 YR | F | 68 KG | 20160726 | US |
125666961 | GLUCOVANCE | Gastrointestinal carcinoma | BRISTOL MYERS SQUIBB | 66.38 YR | F | 69 KG | 20160718 | US |
126858251 | GLUCOVANCE | Gastrointestinal carcinoma | AVENTIS | 66.00 YR | F | 69 KG | 20160825 | US |
Total Records: 4 Number of Pages: 1